Abstracts of Oral and Poster Presentations

Jeffrey Wilkins, Hala Al – Ali, Sharifa Al – Emadi, Abdullah Al – Johi

 
The aim of the presentation is to address the following 12 questions as we present a review of salient summary data, and a description of the clinical challenges and opportunities found in Naufar’s first 16 months of operation.
 
1. What are Naufar’s mission, vision, and values?
2. What is Naufar’s eligibility criteria?
3. How will Naufar work collaboratively with HMC?
4. What are the demographics of Naufar’s clients?
5. What substances are being used by our clients?
6. What is the overall scope of the clinical needs of our clients and their families?
7. What are the qualifications and specialties of Naufar’s staff?
8. What are the assessment and treatment methodologies employed?
9. Does Naufar work with the Ministry of Interior, and, if so, in what capacity?
10. What Qatar healthcare and social agencies does Naufar work with?
11. Will Naufar have its own annual conference?
12. When will Naufar move into its permanent facility in Abu Hamour?
 
We will present data demonstrating the patterns of substance use by our clients from April, 2015 through August, 2016. In particular we will demonstrate how an apparent significant increase in availability of heroin in February, 2016 has directly influenced the clinical presentations of our clients and the impact that this significant increase in heroin use has had on their friends and families.
 
Naufar has created an integrative approach to the treatment of its clients by imbedding specialized staff not generally found in substance abuse treatment centers (e.g. experts in mental health, including child and adolescent psychiatry, family therapy and expressive arts, physiotherapy and kinesiology/movement, and occupational therapy).